US Stock MarketDetailed Quotes

Contineum Therapeutics (CTNM)

Watchlist
  • 12.140
  • +0.300+2.53%
Trading Jan 16 14:52 ET
443.47MMarket Cap-5.53P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Contineum Therapeutics (CTNM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
50M
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--50M
--0
Cost of revenue
Gross profit
Operating expense
15.09%14.93M
63.58%17.9M
82.38%18.11M
50.03%50.89M
76.18%17.05M
60.79%12.97M
-1.08%10.94M
94.13%9.93M
49.31%33.92M
77.57%9.68M
Selling and administrative expenses
21.38%3.94M
26.16%3.84M
104.37%4.4M
97.34%12.47M
142.31%4.03M
106.75%3.25M
89.83%3.04M
45.11%2.15M
8.48%6.32M
11.30%1.66M
-General and administrative expense
21.38%3.94M
26.16%3.84M
104.37%4.4M
97.34%12.47M
142.31%4.03M
106.75%3.25M
89.83%3.04M
45.11%2.15M
8.48%6.32M
11.30%1.66M
Research and development costs
12.99%10.99M
77.99%14.06M
76.29%13.71M
39.20%38.42M
62.44%13.02M
49.68%9.73M
-16.48%7.9M
114.15%7.78M
63.39%27.6M
102.63%8.01M
Operating profit
-15.09%-14.93M
-63.58%-17.9M
-82.38%-18.11M
-416.56%-50.89M
-76.18%-17.05M
-60.79%-12.97M
-128.11%-10.94M
-94.13%-9.93M
170.76%16.08M
-77.57%-9.68M
Net non-operating interest income expense
-28.60%1.96M
1.40%2.03M
37.53%2.25M
102.48%8.91M
41.23%2.53M
57.89%2.74M
255.42%2M
429.45%1.64M
1,079.09%4.4M
642.74%1.79M
Non-operating interest income
-28.60%1.96M
1.40%2.03M
37.53%2.25M
93.33%8.91M
41.23%2.53M
57.89%2.74M
194.70%2M
307.98%1.64M
505.26%4.61M
423.39%1.79M
Non-operating interest expense
----
----
----
--0
--0
--0
--0
--0
-46.39%208K
--0
Other net income (expense)
638.24%183K
-153.03%-167K
-5.69%-130K
-109.98%-269K
-4.55%-46K
5.56%-34K
-102.36%-66K
-583.33%-123K
241.40%2.7M
98.09%-44K
Gain on sale of security
----
----
----
-2,220.00%-106K
-66.67%1K
----
450.00%11K
---117K
66.67%5K
200.00%3K
Special income (charges)
----
----
----
--0
--0
--0
--0
----
257.79%2.87M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
-257.79%-2.87M
--0
Other non- operating income (expenses)
638.24%183K
-116.88%-167K
-2,066.67%-130K
7.91%-163K
0.00%-47K
5.56%-34K
-1.32%-77K
66.67%-6K
-92.39%-177K
-370.00%-47K
Income before tax
-24.59%-12.79M
-78.04%-16.04M
-89.97%-15.99M
-282.38%-42.26M
-83.67%-14.57M
-61.20%-10.27M
-121.30%-9.01M
-74.48%-8.42M
195.53%23.17M
-5.56%-7.93M
Income tax
0
0
0
0
0
450K
-161K
Net income
-24.59%-12.79M
-78.04%-16.04M
-89.97%-15.99M
-285.99%-42.26M
-87.48%-14.57M
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
Net income continuous Operations
-24.59%-12.79M
-78.04%-16.04M
-89.97%-15.99M
-285.99%-42.26M
-87.48%-14.57M
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
Minority interest income
Net income attributable to the parent company
-24.59%-12.79M
-78.04%-16.04M
-89.97%-15.99M
-285.99%-42.26M
-87.48%-14.57M
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
-24.59%-12.79M
-78.04%-16.04M
-89.97%-15.99M
-285.99%-42.26M
-179.24%-14.57M
-64.25%-10.27M
-253.50%-9.01M
-74.48%-8.42M
193.68%22.72M
344.68%18.38M
Basic earnings per share
-12.50%-0.45
-58.97%-0.62
-99.29%-0.62
-359.60%-2.18
-182.43%-0.56
-73.13%-0.4
-210.80%-0.39
-7.53%-0.3111
157.73%0.8397
250.79%0.6793
Diluted earnings per share
-12.50%-0.45
-58.97%-0.62
-99.29%-0.62
-359.60%-2.18
-182.43%-0.56
-73.13%-0.4
-334.88%-0.39
-7.53%-0.3111
157.73%0.8397
250.79%0.6793
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000050M0
Operating revenue --0--0--0--0--0--0--0--0--50M--0
Cost of revenue
Gross profit
Operating expense 15.09%14.93M63.58%17.9M82.38%18.11M50.03%50.89M76.18%17.05M60.79%12.97M-1.08%10.94M94.13%9.93M49.31%33.92M77.57%9.68M
Selling and administrative expenses 21.38%3.94M26.16%3.84M104.37%4.4M97.34%12.47M142.31%4.03M106.75%3.25M89.83%3.04M45.11%2.15M8.48%6.32M11.30%1.66M
-General and administrative expense 21.38%3.94M26.16%3.84M104.37%4.4M97.34%12.47M142.31%4.03M106.75%3.25M89.83%3.04M45.11%2.15M8.48%6.32M11.30%1.66M
Research and development costs 12.99%10.99M77.99%14.06M76.29%13.71M39.20%38.42M62.44%13.02M49.68%9.73M-16.48%7.9M114.15%7.78M63.39%27.6M102.63%8.01M
Operating profit -15.09%-14.93M-63.58%-17.9M-82.38%-18.11M-416.56%-50.89M-76.18%-17.05M-60.79%-12.97M-128.11%-10.94M-94.13%-9.93M170.76%16.08M-77.57%-9.68M
Net non-operating interest income expense -28.60%1.96M1.40%2.03M37.53%2.25M102.48%8.91M41.23%2.53M57.89%2.74M255.42%2M429.45%1.64M1,079.09%4.4M642.74%1.79M
Non-operating interest income -28.60%1.96M1.40%2.03M37.53%2.25M93.33%8.91M41.23%2.53M57.89%2.74M194.70%2M307.98%1.64M505.26%4.61M423.39%1.79M
Non-operating interest expense --------------0--0--0--0--0-46.39%208K--0
Other net income (expense) 638.24%183K-153.03%-167K-5.69%-130K-109.98%-269K-4.55%-46K5.56%-34K-102.36%-66K-583.33%-123K241.40%2.7M98.09%-44K
Gain on sale of security -------------2,220.00%-106K-66.67%1K----450.00%11K---117K66.67%5K200.00%3K
Special income (charges) --------------0--0--0--0----257.79%2.87M--0
-Less:Other special charges ---------------------------------257.79%-2.87M--0
Other non- operating income (expenses) 638.24%183K-116.88%-167K-2,066.67%-130K7.91%-163K0.00%-47K5.56%-34K-1.32%-77K66.67%-6K-92.39%-177K-370.00%-47K
Income before tax -24.59%-12.79M-78.04%-16.04M-89.97%-15.99M-282.38%-42.26M-83.67%-14.57M-61.20%-10.27M-121.30%-9.01M-74.48%-8.42M195.53%23.17M-5.56%-7.93M
Income tax 00000450K-161K
Net income -24.59%-12.79M-78.04%-16.04M-89.97%-15.99M-285.99%-42.26M-87.48%-14.57M-64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M
Net income continuous Operations -24.59%-12.79M-78.04%-16.04M-89.97%-15.99M-285.99%-42.26M-87.48%-14.57M-64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M
Minority interest income
Net income attributable to the parent company -24.59%-12.79M-78.04%-16.04M-89.97%-15.99M-285.99%-42.26M-87.48%-14.57M-64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders -24.59%-12.79M-78.04%-16.04M-89.97%-15.99M-285.99%-42.26M-179.24%-14.57M-64.25%-10.27M-253.50%-9.01M-74.48%-8.42M193.68%22.72M344.68%18.38M
Basic earnings per share -12.50%-0.45-58.97%-0.62-99.29%-0.62-359.60%-2.18-182.43%-0.56-73.13%-0.4-210.80%-0.39-7.53%-0.3111157.73%0.8397250.79%0.6793
Diluted earnings per share -12.50%-0.45-58.97%-0.62-99.29%-0.62-359.60%-2.18-182.43%-0.56-73.13%-0.4-334.88%-0.39-7.53%-0.3111157.73%0.8397250.79%0.6793
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.30%
Sample Name
Sample Code
 +2.86%
Sample Name
Sample Code
 +2.56%
4
Broadcom
AVGO
+1.44%
5
Block
XYZ
+1.42%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.66%
Sample Name
Sample Code
 +10.34%
Sample Name
Sample Code
 +9.80%
4
Kingsoft Cloud
KC
+7.04%
5
United Microelectronics
UMC
+6.20%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -